CYP1B1 and metabolic dysfunction-associated steatotic liver disease: Mycotoxins have been widely recognized as a risk factor for NAFLD (Cheung et al., 2020, Kawahara et al., 2022 Oct).The activation of CYP1B1-SCD1 plays a crucial role in the occurrence and development of NAFLD (Bock, 2020, Lee et al., 2021).